Imperial College London

Jiri Pavlu

Faculty of MedicineDepartment of Immunology and Inflammation

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3313 8117j.pavlu Website

 
 
//

Location

 

Leuka Building R2.20Hammersmith HospitalHammersmith Campus

//

Summary

 

Summary

Dr Jiri Pavlu is a Consultant Haematologist at Hammersmith Hospital and Honorary Clinical Senior Lecturer at Imperial College London. He is the clinical lead for acute leukaemia and myelodysplastic syndromes at Imperial College Healthcare.

He is active in clinical research and uses the latest drugs and treatments to offer highly personalised care. His scientific research focuses acute leukaemia and on improvements in the safety and patient outcomes of transplantation. He is an active member of the acute leukaemia working parties in both the National Cancer Research Institute and the European Bone Marrow Transplantation Society (EBMT).  He is also an accredited transplantation quality assurance inspector (Joint Accreditation Committee – International Society for Cellular Therapy & EBMT).

Publications

Journals

Fernando F, Robertson HF, El-Zahab S, et al., 2021, How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia., Clin Hematol Int, Vol:3, Pages:130-141

Loke J, Metzner M, Boucher R, et al., 2021, Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy, British Journal of Haematology, Vol:196, ISSN:0007-1048, Pages:368-373

Innes AJ, Mullish BH, Ghani R, et al., 2021, Fecal microbiota transplant mitigates adverse outcomes in patients colonized with multidrug-resistant organisms undergoing allogeneic hematopoietic cell transplantation, Frontiers in Cellular and Infection Microbiology, Vol:11, ISSN:2235-2988, Pages:1-8

Geva M, Pryce A, Shouval R, et al., 2021, High lactate dehydrogenase at time of admission for allogeneic hematopoietic transplantation associates to poor survival in acute myeloid leukemia and non-Hodgkin lymphoma, Bone Marrow Transplantation, Vol:56, ISSN:0268-3369, Pages:2690-2696

Conference

Ruggeri A, Galimard JE, Labopin M, et al., 2021, Comparison of Haploidentical Peripheral Blood Cell Transplantation Using Post-Transplant Cyclophosphamide With Double Cord Blood Transplantation in Adults With Acute Leukemia, SPRINGERNATURE, Pages:24-25, ISSN:0268-3369

More Publications